In vitro and in vivo characterization of Lu AA41178: A novel, brain penetrant, pan-selective Kv7 potassium channel opener with efficacy in preclinical models of epileptic seizures and psychiatric disordersMorten Grupe, Jesper F. Bastlund, Kristen Frederiksen et al.|European Journal of Pharmacology|2020Cited by 19
Advancements in NMDA Receptor-Targeted Antidepressants: From <scp>d</scp>-Cycloserine Discovery to Preclinical Efficacy of Lu AF90103Erhad Ascic, John Paul Kilburn, Mauro Marigo et al.|Journal of Medicinal Chemistry|2024Cited by 2